Galectin-3, a β-galactose-binding lectin, is widely recognized as a key mediator of inflammation and fibrogenesis and has been proposed as a prognostic biomarker for hepatocellular carcinoma [46,47,48]. The gene discussed is LGALS3; the disease is hepatocellular carcinoma.